Title: Septic Cardiomyopathy<br/>Author: Mike Winters<br/><a href='http://umem.org/profiles/faculty/141/'>[Click to email author]</a><hr/><p>
        <strong><u>Septic Cardiomyopathy</u></strong></p>
<ul>
        <li>
                Cardiac dysfunction is common in patients with sepsis.</li>
        <li>
                Though mulitiple definitions exist, sepsis cardiomyopathy (SCM) is generally defined as an "acute syndrome of cardiac dysfunction that is unrelated to ischemia in patients with sepsis".</li>
        <li>
                Depending on the study, the incidence of SCM ranges anwywhere from 7% to 70%.</li>
        <li>
                Risk factors for SCM include:
                <ul>
                        <li>
                                Male</li>
                        <li>
                                Younger age</li>
                        <li>
                                High lactate at admission</li>
                        <li>
                                History of heart failure</li>
                </ul>
        </li>
        <li>
                The best approach to treating patients with SCM is to maximize your treatment of sepsis.</li>
        <li>
                Dobutamine is no longer routinely recommended for SCM based solely on measurements of ScvO2.</li>
</ul>
<fieldset><legend>References</legend>

                <p>
        Beesley S, et al. Septic cardiomyopathy. <em>Crit Care Med</em> 2018. [epub ahead of print]</p>
</fieldset>